Sensitization to modified colophonium in glucose sensors: Another problem for diabetes patients

Olivier Aerts is investigator, consultant and/or speaker for Leo Pharma and L'Oréal/La Roche Posay. The other authors have no conflicts to declare. Appendix S1 Supporting Information Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.